SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells

PeerJ. 2022 Oct 3:10:e14084. doi: 10.7717/peerj.14084. eCollection 2022.

Abstract

Background: RNA-binding proteins (RBPs) have important roles in orchestrating posttranscriptional regulation and modulating many tumorigenesis events. SERBP1 has been recognized as an important regulator in multiple cancers, while it remains unclear whether SERBP1-regulated gene expression at the transcriptome-wide level is significantly correlated with tumorigenesis.

Methods: We overexpressed SERBP1 in HeLa cells and explored whether SERBP1 overexpression (SERBP1-OE) affects the proliferation and apoptosis of HeLa cells. We analyzed the transcriptome-wide gene expression changes and alternative splicing changes mediated by SERBP1-OE using the transcriptome sequencing method (RNA-seq). RT-qPCR was conducted to assay SERBP1-regulated alternative splicing.

Results: SERBP1-OE induced the apoptosis of HeLa cells. The downregulated genes were strongly enriched in the cell proliferation and apoptosis pathways according to the GO analysis, including FOS, FOSB, PAK6 and RAB26. The genes undergoing at least one SERBP1-regulated alternative splicing event were enriched in transcriptional regulation, suggesting a mechanism of the regulation of gene expression, and in pyruvate and fatty acid metabolic processes critical for tumorigenesis events. The SERBP1-regulated alternative splicing of ME3, LPIN3, CROT, PDP1, SLC27A1 and ALKBH7 was validated by RT-qPCR analysis.

Conclusions: We for the first time demonstrated the cellular function and molecular targets of SERBP1 in HeLa cells at transcriptional and post-transcriptional levels. The SERBP1-regulated gene expression and alternative splicing networks revealed by this study provide important information for exploring the functional roles and regulatory mechanisms of SERBP1 in cancer development and progression.

Keywords: Alternative splicing; Apoptosis; Differentially expressed genes; SERBP1; Tumorigenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AlkB Enzymes / genetics
  • Alternative Splicing* / genetics
  • Carcinogenesis
  • Cell Proliferation / genetics
  • HeLa Cells
  • Humans
  • Mitochondrial Proteins / genetics
  • Transcriptome*

Substances

  • ALKBH7 protein, human
  • AlkB Enzymes
  • Mitochondrial Proteins

Grants and funding

This work was supported by the Fundamental Research Funds for the Central Universities (Grant No. 2042019kf0161) and by Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund, (Project CXPY2020008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.